We are pleased to announce that the comment period is now open for the 2023 Measure Set Review (MSR) Draft Report. The goal of MSR is to optimize the Centers for Medicare & Medicaid Services (CMS) Medicare quality programs measure portfolio via measure removal recommendations. The 2023 MSR will review the measures included in the CMS End-Stage Renal Disease Quality Incentive Program (ESRD QIP). The draft report presents our assessment of the measures.
Commenters are encouraged to share their support for or concerns of a measure’s retention or removal from the ESRD QIP upon review of the evidence presented in the draft report. All comments received will be reviewed by the MSR Recommendation Group for discussion and vote during their October measure review meeting. The comment period will remain open for 15 calendar days until 11:59 p.m. (ET) on September 25, 2023.